AUCTUS Capital exits PharmaLex to AmerisourceBergen
AmerisourceBergen is expected to pay €1.28 billion in cash for the firm.
AmerisourceBergen is expected to pay €1.28 billion in cash for the firm.
Copyright PEI Media
Not for publication, email or dissemination
